600538.SH
Beihai Gofar Chuanshan Biological Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 4.32
+4.60%Year over year
Reported trailing growth
- Revenue
- +0.2%
- EBITDA
- —
- EBIT
- -25.2%
- EPS
- -26.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.6%
- EBITDA
- +9.2%
- EBIT
- +7.9%
- Net income
- +6.6%
- EPS
- +5.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026